Covidien LP
Country not established
- Devices
- 9,818
- FDA recalls
- 19998 ongoing since 2021 (107 open in total)
At a glance
Market reach
- United States
- FDA recalls
Catalogue
Search and filter all 9,818 devicesShowing 1-50 of 9,818
Company details
- DUNS number
- 058614483
- Phone
- +1(508)261-8000
FDA recalls
Recalls initiated per year
- 2017 1
- 2018 0
- 2019 0
- 2020 9
- 2021 26
- 2022 15
- 2023 38
- 2024 14
- 2025 2
- 2026 6
2026
- 24 Jun 2026 Z-2918-2026 Class II Ongoing Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
Full distribution text
- 24 Jun 2026 Z-2919-2026 Class II Ongoing Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
Full distribution text
- 24 Jun 2026 Z-2920-2026 Class II Ongoing Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
Full distribution text
- 24 Jun 2026 Z-2921-2026 Class II Ongoing Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
Full distribution text
- 24 Jun 2026 Z-2922-2026 Class II Ongoing Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
Full distribution text
- 15 Apr 2026 Z-2281-2026 Class II Ongoing The presence of holes in the pouch may compromise the package s ability to maintain the sterile barrier and protect the product from environmental exposure.
- 24 Jun 2026 Z-2918-2026 Class II Ongoing Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
2025
- 25 Sep 2025 Z-0485-2026 Class II Ongoing A manufacturing issue could lead to a malformed cover tube press which can lead to internal components' movement during firing - leading to the potential for uncontrolled motion.
Full distribution text
- 25 Sep 2025 Z-0486-2026 Class II Ongoing A manufacturing issue could lead to a malformed cover tube press which can lead to internal components' movement during firing - leading to the potential for uncontrolled motion.
Full distribution text
- 25 Sep 2025 Z-0485-2026 Class II Ongoing A manufacturing issue could lead to a malformed cover tube press which can lead to internal components' movement during firing - leading to the potential for uncontrolled motion.
2024
- 19 Sep 2024 Z-0257-2025 Class II Ongoing Specific lots of the Chameleon PTA Balloon Catheter failed to meet in-house balloon pressure testing.
Full distribution text
- 15 Apr 2024 Z-1891-2024 Class II Ongoing Potential damage to the cartridge can result in poor staple formation and/or incomplete staple line, may cause a delay in surgery
Full distribution text
- 19 Sep 2024 Z-0257-2025 Class II Ongoing Specific lots of the Chameleon PTA Balloon Catheter failed to meet in-house balloon pressure testing.
Show the 25 most recent of 199 recalls
2024
- 15 Mar 2024 Z-1634-2024 Class II Ongoing Products may not be heparin coated as indicated on the label-leads to a potential loss of benefit due to the absence of the heparin coating
Full distribution text
- 15 Mar 2024 Z-1635-2024 Class II Ongoing Products may not be heparin coated as indicated on the label-leads to a potential loss of benefit due to the absence of the heparin coating
Full distribution text
- 28 Feb 2024 Z-1465-2024 Class II Ongoing The potential for trocar seal disengagement when using mesh products incorrectly with the device.
Full distribution text
- 28 Feb 2024 Z-1466-2024 Class II Ongoing The potential for trocar seal disengagement when using mesh products incorrectly with the device.
Full distribution text
- 28 Feb 2024 Z-1467-2024 Class II Ongoing The potential for trocar seal disengagement when using mesh products incorrectly with the device.
Full distribution text
- 28 Feb 2024 Z-1468-2024 Class II Ongoing The potential for trocar seal disengagement when using mesh products incorrectly with the device.
Full distribution text
- 28 Feb 2024 Z-1469-2024 Class II Ongoing The potential for trocar seal disengagement when using mesh products incorrectly with the device.
Full distribution text
- 28 Feb 2024 Z-1470-2024 Class II Ongoing The potential for trocar seal disengagement when using mesh products incorrectly with the device.
Full distribution text
- 28 Feb 2024 Z-1471-2024 Class II Ongoing The potential for trocar seal disengagement when using mesh products incorrectly with the device.
Full distribution text
- 14 Feb 2024 Z-1457-2024 Class II Ongoing Under certain firing conditions, reloads were found to articulate in an uncontrolled manner potentially causing disruption to the staple line. The issue is related to components in impacted reloads that are not fully secure, which leads to uncontrolled articulation. The issue can occur using either the Endo GIA" Ultra Universal Stapler or Signia" Stapling System.
- 14 Feb 2024 Z-1458-2024 Class II Ongoing Under certain firing conditions, reloads were found to articulate in an uncontrolled manner potentially causing disruption to the staple line. The issue is related to components in impacted reloads that are not fully secure, which leads to uncontrolled articulation. The issue can occur using either the Endo GIA" Ultra Universal Stapler or Signia" Stapling System.
- 25 Jan 2024 Z-1697-2024 Class II Ongoing One lot of product was exposed to more than the approved number of Ethylene Oxide (EO) sterilization cycles. This may decrease the tensile strength of the sutures over time, which could result in harms such as wound dehiscence, hemorrhage, blood loss, bleeding, tissue breakdown, peritonitis, unspecified infection, vision loss (when used in ophthalmic application), and/or prolonged surgery.
- 15 Mar 2024 Z-1634-2024 Class II Ongoing Products may not be heparin coated as indicated on the label-leads to a potential loss of benefit due to the absence of the heparin coating
2023
- 21 Dec 2023 Z-0844-2024 Class II Ongoing Specific lots of sutures were sterilized with gamma doses that exceeded the range approved. The extra gamma levels may decrease the strength of the sutures over time, which could result in harms such as wound dehiscence and hemorrhage/blood loss/ bleeding at a critical level.
Full distribution text
- 21 Dec 2023 Z-0845-2024 Class II Ongoing Specific lots of sutures were sterilized with gamma doses that exceeded the range approved. The extra gamma levels may decrease the strength of the sutures over time, which could result in harms such as wound dehiscence and hemorrhage/blood loss/ bleeding at a critical level.
Full distribution text
- 16 Nov 2023 Z-0986-2024 Class II Ongoing Packaging of the device may cause a low seal strength in the side seal of the foil pouch potentially resulting in a sterile/moisture barrier breach, compromising the product sterility
- 21 Dec 2023 Z-0844-2024 Class II Ongoing Specific lots of sutures were sterilized with gamma doses that exceeded the range approved. The extra gamma levels may decrease the strength of the sutures over time, which could result in harms such as wound dehiscence and hemorrhage/blood loss/ bleeding at a critical level.
Frequently asked questions
How many devices does Covidien LP have in the registry?
The registry currently lists 9818 devices for Covidien LP. Devices recorded under merged duplicate company entries are counted once.
Which registries list Covidien LP's devices?
Among its 50 most recently registered devices, Covidien LP has devices listed in EUDAMED (2 devices) and FDA GUDID (50 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Covidien LP's devices fall under?
Among its 50 most recently registered devices, the classes recorded for Covidien LP's devices are Class I and Class II. Each device page shows its own class and authorisation.
Are there FDA recall records for Covidien LP?
FDA recall records list 199 recalls initiated by Covidien LP, the most recent initiated on 24 Jun 2026. 107 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from Covidien LP in the registry?
The most recently registered devices listed for Covidien LP include LigaSure MRASILF19, Shiley 110860, Shiley 110865 and Shiley 110870.